➢ Non-adherence to treatment regimens and medication therapy has long been recognized as a substantial roadblock to achieving improved patient health outcomes.1

It can be a challenge for people to make healthy choices—and the data prove it.

It can be a challenge for people to make healthy choices—and the data prove it.

It is well documented that medication non-adherence affects Americans of all ages, regardless of gender or race and is just as likely to involve high-income, well-educated people as those at lower socioeconomic levels and patient’s health complications can accelerate.2

The Challenge

The Consequences of Medication Non-adherence

 
50% of patients do not take their medications correctly (non-adherence)
 

Up to 2/3 of all medication-related hospitalizations are the result of poor medication adherence
 

Medication non-adherences costs the US Health care system up to $290 Billion annually or 10% of the total U.S. healthcare costs

Medication non-adherence—linked to Mortality, Hospitalizations, and Emergency Department visits

Medication non-adherence—linked to Mortality, Hospitalizations, and Emergency Department visits

Medication non-adherence is a problem that applies to all chronic conditions; affects all demographic and socio-economic levels; diminishes the ability to treat diabetes, heart disease, cancer, asthma, and many other diseases; and, results in suffering and even death.

Learn More

  • Non-adherence causes 30% to 50% of treatment failures and 125,000 deaths annually
  • Non-adherence to statin medications increased relative risk for death (up to 25%)
  • Non-adherence to cardio protective medications increased risk of cardiovascular hospitalizations (up to 40%) and deaths (up to 80%)3
It’s time to treat patients’ Adherence to their medication therapies and treatment plans as a critical  health care issue

It’s time to treat patients’ Adherence to their medication therapies and treatment plans as a critical health care issue

Americans have inadequate knowledge about the significance of medication Adherence as a crucial element of their improved health. Today’s “call to action” for clinicians is to employ interactive technology to expand their treatment and medication ADHERENCE voice, reach and care beyond the walls of the medical office, pharmacy or other traditional practice settings.

Learn More

The World Health Organization (WHO) Adherence Report findings indicate that increasing the effectiveness of Adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatment. 4 This research supports former US Surgeon General C. Everett Koop’s mantra that “Drugs don’t work in patients who do not take them” and …they have made the case that patient-centered and medication Adherence be at the core of reforming America’s healthcare delivery system. Here are some shocking facts about non-adherence.

 

DIABETES:

Over half of adults in the US have Diabetes or pre-Diabetes. With Diabetes a recent study shows that many have reported the percent of patients being “non-adherent” ranging up to 64% for oral medications and up to 46% for users of insulin. 5

According to the latest figures from the U.S. Centers for Disease Control and Prevention:

  • 29.1 million people in the U.S. are diagnosed with diabetes
  • 8.1 million are undiagnosed
  • 1.4 million people are diagnosed with diabetes each year
  • Diabetes is the 7th leading cause of death in the U.S.

GLAUCOMA:

“Non-adherence to medication therapy is an ongoing barrier to glaucoma treatment with more than half of patients remaining non-adherent even after significant vision loss.”

“Glaucoma is a chronic, irreversible, optic neuropathy that can lead to permanent vision loss; it is the second leading cause of blindness worldwide and affects up to 60 million people. Eye drop medications are prescribed to preserve visual function and quality of life… and regular eye drop use reduces the rate of glaucoma progression.” 6

KIDNEY DISEASE:

Medication Adherence in kidney transplant patients is imperative to reduce the chances of kidney rejection; yet, up to 36.4% of patients are non-adherent to their medication therapy. 7

The increasing prevalence of chronic kidney disease, the relative shortage of kidney donors and the economic and health-related costs of kidney transplant rejection make Adherence to medication therapy imperative to prevent kidney rejection—there are currently over 130,000 people awaiting kidney transplants. 8

Who is paying the price for the epidemic of poor medication Adherence?

Who is paying the price for the epidemic of poor medication Adherence?

We all are—and the costs are substantial.

While Americans are being treated in record numbers for a long list of chronic conditions, little is being done to support patients who are not following (non-adherence) their prescribed treatment regimens and their medication therapy—a medical failing that is costing our nation’s healthcare system an estimated 290 billion annually. This amount represents up to 10% of the total US health care costs. 3

Marilyn Shreve TIPHealth® Tailored Interactive Patient Health®
TIPHealth® is dedicated to Improving Treatment and Medication Adherence in America
Send